Press Release | October 28, 2019
Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting
Read More
News | October 23, 2019
Novartis bets $80M on Pliant’s preclinical NASH prospect
Read More
News | July 19, 2019
Pyxis Oncology Raises $22 Million Series A
Read More
News | July 16, 2019
Genentech inks its latest discovery deal — this time turning to RNA upstart Skyhawk
Read More
